Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
3,800,844
-
Shares change
-
+18,659
-
Total reported value, excl. options
-
$148,570,433
-
Value change
-
-$692,933
-
Put/Call ratio
-
68700%
-
Number of buys
-
36
-
Number of sells
-
-30
-
Price
-
$39.09
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q4 2016
89 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q4 2016.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,800,844 shares
.
Largest 10 shareholders include UBS Group AG (634,211 shares), BANK OF AMERICA CORP /DE/ (593,917 shares), GOLDMAN SACHS GROUP INC (517,092 shares), MORGAN STANLEY (322,118 shares), Wharton Business Group, LLC (236,005 shares), Psagot Investment House Ltd. (206,212 shares), BARCLAYS PLC (200,560 shares), Baird Financial Group, Inc. (107,705 shares), WELLS FARGO & COMPANY/MN (100,620 shares), and Hochman Cole Investment Advisors, Inc. (71,801 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.